Coronavirus Vaccine Updates:  Oxford’s Covishield Set to provide Vaccine by End of Year in India, Others by Early Next Year

Coronavirus Vaccine Updates:  Oxford’s Covishield Set to provide Vaccine by End of Year in India, Others by Early Next Year

Coronavirus virus vaccine update: After promising results by experimental vaccine candidates from Oxford University and Modern Inc. in preliminary human trials, Covishield has gained significant attention by raising expectations of its initial availability by the end of this year.

However, a World Health Organization (WHO) expert told Reuters that the first batch of COVID-19 vaccines are “realistic” only expected by early 2021.

Many states under lockdown “Many vaccines are now in Phase 3 trials and none have failed, so far, causing immune response In terms of safety or ability to do it.

In reality, this is going to be the first part of next year, before we start seeing people getting vaccinated, “WHO chief, Mike Ryan, quoted Royals Said.

Notably, earlier this week, India launched the experimental COVID-19 vaccine from Oxford and AstraZeneca – ChAdOx1 India has shown a safe and immune response to clinical trials conducted on people between the ages of 18 and 55.

The Pune-based Serum Institute of India, which acquired the production, said that by the end of August Intends to make at least 2-3 million doses for 50 percent of the population.

SII CEO Adar Poon Jawala said, “These vaccines will be for middle and low-income countries in India and around the world.” Poonawalla also confirmed that the vaccine, if successful, will be capped at a price of Rs 1,000 per dose so that all sects And people of the economic classes can afford it.